Does the CHA2DS2-Vasc score predict procedural and short-term outcomes in patients undergoing transcatheter aortic valve implantation?
Open Access
- 22 October 2015
- journal article
- research article
- Published by BMJ in Open Heart
- Vol. 2 (1) , e000170
Abstract
Background: Transcatheter aortic valve implantation (TAVI) is associated with periprocedural and postprocedural morbidity and mortality. Currently, there is a paucity of risk stratification models for potential TAVI candidates. We employed the CHA2DS2-Vasc score to quantify the risk of 30-day mortality and morbidity in patients undergoing TAVI. Methods and results: A retrospective analysis of registry data for consecutive patients undergoing TAVI at 3 tertiary centres in Northwest England between 2008 and 2013. The CHA2DS2-Vasc score and its modification—the R2CHA2DS2-Vasc score, which includes pre-existing renal impairment and pre-existing conduction abnormality (right bundle branch block/left bundle branch block, RBBB/LBBB)—were calculated for all patients. A total of 313 patients with a mean age of 80 (79.1–80.8) years underwent TAVI. The implanted devices were either the CoreValve or the Edwards-SAPIEN prosthesis. The 30-day mortality was 14.3% in those with a CHA2DS2-Vasc score ≥6, whereas it was only 6.2% in those with a score 2-CHA2DS2-Vasc score, the difference was more pronounced with a 30-day mortality of 22.6% in those patients with an R2-CHA2DS2-Vasc score ≥7 compared to 6.0% in those with a R2-CHA2DS2-Vasc score 2DS2-Vasc score (hazard ratio (HR)= 2.71, (1.01 to 7.31); p2CHA2DS2-Vasc score (HR=4.27 (1.51 to 12.07); p=0.006) with 30-day mortality. Conclusions: Our study demonstrates the potential use of the CHA2DS2-Vasc or the R2CHA2DS2-Vasc score to quantify the risk of mortality in patients undergoing TAVI. This could have significant implications in terms of clinical as well as patients’ decision-making.Keywords
This publication has 23 references indexed in Scilit:
- Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patientsEuroIntervention, 2012
- Risk for Permanent Pacemaker After Transcatheter Aortic Valve Implantation: A Comprehensive Analysis of the LiteratureJournal of Cardiovascular Electrophysiology, 2011
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsNew England Journal of Medicine, 2011
- Renal Function as Predictor of Mortality in Patients After Percutaneous Transcatheter Aortic Valve ImplantationJACC: Cardiovascular Interventions, 2010
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic StenosisThe Annals of Thoracic Surgery, 2006
- Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic StenosisCirculation, 2002
- European system for cardiac operative risk evaluation (EuroSCORE)European Journal of Cardio-Thoracic Surgery, 1999
- ACC/AHA guidelines for the management of patients with valvular heart diseaseJACC, 1998
- Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.Circulation, 1994